David P. Southwell - Director at Ptc Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
PTCT on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David P. Southwell since 7/15/2023

Holdings reported by David P. Southwell for Ptc Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 12.9 K $422 K $32.82 May 8, 2024 Direct
Stock Option (Right to Buy) 10 K $271 K $27.05 Feb 15, 2024 Direct Common Stock
Common Stock 1.65 K $54.2 K $32.82 May 8, 2024 By trust

Transactions reported by David P. Southwell for Ptc Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership